AU7592998A - Modulators of tissue regeneration - Google Patents

Modulators of tissue regeneration

Info

Publication number
AU7592998A
AU7592998A AU75929/98A AU7592998A AU7592998A AU 7592998 A AU7592998 A AU 7592998A AU 75929/98 A AU75929/98 A AU 75929/98A AU 7592998 A AU7592998 A AU 7592998A AU 7592998 A AU7592998 A AU 7592998A
Authority
AU
Australia
Prior art keywords
modulators
tissue regeneration
regeneration
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75929/98A
Inventor
Richard L. Cate
Catherine A. Hession
Michele Sanicola-Nadel
Henry Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen Inc
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of AU7592998A publication Critical patent/AU7592998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU75929/98A 1997-05-23 1998-05-22 Modulators of tissue regeneration Abandoned AU7592998A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4749097P 1997-05-23 1997-05-23
US4749197P 1997-05-23 1997-05-23
US60047490 1997-05-23
US60047491 1997-05-23
PCT/US1998/010547 WO1998053071A1 (en) 1997-05-23 1998-05-22 Modulators of tissue regeneration

Publications (1)

Publication Number Publication Date
AU7592998A true AU7592998A (en) 1998-12-11

Family

ID=26725083

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75929/98A Abandoned AU7592998A (en) 1997-05-23 1998-05-22 Modulators of tissue regeneration

Country Status (5)

Country Link
EP (1) EP0983357A1 (en)
JP (1) JP2002516572A (en)
AU (1) AU7592998A (en)
CA (1) CA2290783A1 (en)
WO (1) WO1998053071A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU757698B2 (en) * 1998-06-01 2003-03-06 Agensys, Inc. Novel serpentine transmembrane antigens expressed in human cancers and uses thereof

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040141975A1 (en) 1998-06-01 2004-07-22 Raitano Arthur B. Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
US20060052321A1 (en) 2002-04-05 2006-03-09 Raitano Arthur B Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer
US6451969B1 (en) 1999-01-15 2002-09-17 The Burnham Institute Methods for inhibiting tumor metastasis, and peptides useful therfor
EP1176200A3 (en) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases or wound healing and their use in indentifying pharmacologically acitve substances
US6717032B2 (en) 2000-07-06 2004-04-06 Deltagen, Inc Transgenic mice containing DEZ orphan receptor gene disruptions
AU2001271902A1 (en) * 2000-07-06 2002-01-21 Deltagen, Inc. Transgenic mice containing targeted gpcr gene disruptions
US20060063230A1 (en) 2000-12-27 2006-03-23 Roman Naworth Sulfatases and methods of use thereof
US20040197784A1 (en) * 2001-02-22 2004-10-07 Miano Joseph Michael Retinoid inducible proteins of vascular smooth muscle cells and uses thereof
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
AUPR470101A0 (en) 2001-05-02 2001-05-24 Murdoch Childrens Research Institute, The A molecular marker
CA2459318C (en) 2001-09-06 2017-09-26 Agensys, Inc. Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
EP1613750B1 (en) 2003-03-19 2015-10-14 Amgen Fremont Inc. Antibodies against t cell immunoglobulin domain and mucin domain 1 (tim-1) antigen and uses thereof
AU2004319915B9 (en) 2004-04-22 2011-12-22 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
JP2009515897A (en) 2005-11-10 2009-04-16 キュラジェン コーポレイション Methods of treating ovarian and renal cancer using antibodies to immunoglobulin domains of murine domain and mucin domain 1 (TIM-1) antigen
DK2502938T3 (en) 2006-10-27 2015-04-20 Genentech Inc Antibodies and immunoconjugates and uses thereof
DK2186889T3 (en) 2007-08-20 2015-06-08 Oncotherapy Science Inc CDCA1 PEPTID AND PHARMACEUTICAL COMPOSITION, INCLUDING THIS
TWI526219B (en) 2008-06-19 2016-03-21 腫瘤療法 科學股份有限公司 Cdca1 epitope peptides and vaccines containing the same
EP2872532A4 (en) 2012-07-10 2016-04-13 Oncotherapy Science Inc Cdca1 epitope peptides for th1 cells and vaccines containing the same
RU2019134462A (en) 2017-04-03 2021-05-05 Ф. Хоффманн-Ля Рош Аг ANTIBODIES BINDING WITH STEAP-1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2206495A (en) * 1994-03-31 1995-10-23 Amur Research Corp. Diagnostic marker and method for determining renal function in mammals
US5552313A (en) * 1994-11-21 1996-09-03 Kansas University DNA encoding mouse phosphotriesterase-related protein
NZ336467A (en) * 1996-05-24 2000-10-27 Gen Hospital Corp Modulators of tissue regeneration using DNA enclding a kidney injury molecule KIM

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU757698B2 (en) * 1998-06-01 2003-03-06 Agensys, Inc. Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
AU757698C (en) * 1998-06-01 2004-04-08 Agensys, Inc. Novel serpentine transmembrane antigens expressed in human cancers and uses thereof

Also Published As

Publication number Publication date
JP2002516572A (en) 2002-06-04
EP0983357A1 (en) 2000-03-08
CA2290783A1 (en) 1998-11-26
WO1998053071A1 (en) 1998-11-26

Similar Documents

Publication Publication Date Title
HUP9902770A3 (en) Modulators of tissue regeneration
AU7592998A (en) Modulators of tissue regeneration
AU2557397A (en) Removal of tissue
AU2218395A (en) Bone regeneration
EP0788804A3 (en) Medical applicator
AU6790998A (en) Suture-passing forceps
AU1408199A (en) Patient support surfaces
AU6506698A (en) Tissue implant
AU6042298A (en) Tissue factor pathway inhibitor-3
AU1036697A (en) Surgical anchorage
AU6034096A (en) Disposable applicator
AU2315797A (en) Promotion of regeneration of organized tissues
AU6928098A (en) Optical modulator
AU5055996A (en) Switched-inverter modulator
AU2749395A (en) Medical use of bromelain
AU4944297A (en) Modulation of apoptosis
AU3145795A (en) Fibrin-cell suspension for construction of new tissue
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU2870597A (en) Treatment of liquid
AU8408498A (en) Surgical handpiece
AU6883398A (en) Methods of treating bone loss
AU1570199A (en) Methods of lyophilizing solutions
AU1112099A (en) Tissue removal
AU2500797A (en) Methods of modulating t-cell activation
AU6893996A (en) Use of catalysts

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase